Cellective BioTherapy Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.5M
- Investors
-
3
Cellective BioTherapy General Information
Description
Developer of a biotechnology platform designed to revolutionize the way to treat immunological diseases. The company's platform provides the ability to expand human B cells for use as autologous cellular immunotherapy for treating cancers, autoimmunity and immunodeficiency, enabling physicians to treat patients without destroying essential cells and their protective functions.
Contact Information
Website
www.cellectivebiotherapy.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 6 Davis Drive
- Research Triangle Park
- Durham, NC 27709
- United States
+1 (919) 000-0000
Cellective BioTherapy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 26-May-2015 | $2.5M | 00.00 | 000.00 | Completed | Startup |
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Early Stage VC | Completed | Startup |
Cellective BioTherapy Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Cellective BioTherapy Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thomas Tedder Ph.D | Founder, Chief Executive Officer, Board Member & President | ||
| Robert Bonczek JD | Chief Financial Officer & Board Member | ||
| Fred Eshelman | Chairman & Assistant Secretary |
Cellective BioTherapy Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Fred Eshelman | Self | Chairman & Assistant Secretary | 000 0000 |
| Robert Bonczek JD | Cellective BioTherapy | Chief Financial Officer & Board Member | 000 0000 |
| Thomas Tedder Ph.D | Cellective BioTherapy | Founder, Chief Executive Officer, Board Member & President | 000 0000 |
Cellective BioTherapy Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Eshelman Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| MedBlue Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Sofinnova Investments | Venture Capital | Minority | 000 0000 | 000000 0 |